Genetics of sudden cardiac death caused by ventricular arrhythmias

Nature Reviews Cardiology

Volumn 11, Issue 2, 2014, Pages 96-111

  Marsman, Roos F ^a   Tan, Hanno L ^a   Bezzina, Connie R ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PDZ PROTEIN; POTASSIUM CHANNEL KCNQ1;

BRUGADA SYNDROME; CARDIOVASCULAR RISK; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CONGESTIVE CARDIOMYOPATHY; DNA SEQUENCE; ELECTROCARDIOGRAM; EXOME; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HERITABILITY; HIGH THROUGHPUT SEQUENCING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INHERITANCE; LONG QT SYNDROME; NONHUMAN; PENETRANCE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RARE DISEASE; REVIEW; SHORT QT SYNDROME; SUDDEN CARDIAC DEATH;

CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; GENETIC TECHNIQUES; HUMANS; PHENOTYPE; RISK FACTORS; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; WORLD HEALTH;

EID: 84893690123     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2013.186     Document Type: Review

References (159)

1. European Heart Rhythm Association et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology committee for practice guidelines. J. Am. Coll. Cardiol. 48, e247-e346 (2006
2. de Vreede-Swagemakers, J. J. et al. Out of hospital cardiac arrest in the 1990's: A population-based study in the Maastricht area on incidence, characteristics and survival. J. Am. Coll. Cardiol. 30, 1500-1505 (1997
3. Hulleman, M et Al. Implantable Cardioverter-defibrillators Have Reduced the Incidence of Resuscitation for out of Hospital Cardiac Arrest Caused by Lethal Arrhythmias. Circulation 126, 815-821 (2012
4. Olde Nordkamp, L. R. et al. The ICD for primary prevention in patients with inherited cardiac diseases: Indications, use, and outcome: A comparison with secondary prevention. Circ. Arrhythm. Electrophysiol. 6, 91-100 (2013
5. Kong, M. H. et al. Systematic review of the incidence of sudden cardiac death in the United States. J. Am. Coll. Cardiol. 57, 794-801 (2011
6. US Department of Commerce US and world population clock [online], http://www.census.gov/popclock (2013
7. Cobb, L. A., Fahrenbruch, C. E., Olsufka, M. & Copass, M. K. Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA 288, 3008-3013 (2002
8. Albert, C M. et al. Prospective study of sudden cardiac death among women in the United States. Circulation 107, 2096-2101 (2003
9. Myerburg, R. J., Kessler, K. M. & Castellanos, A. Sudden cardiac death: Epidemiology, transient risk, and intervention assessment. Ann. Intern. Med. 119, 1187-1197 (1993
10. Bardai, A et al. Epilepsy is a risk factor for sudden cardiac arrest in the general population. PLoS ONE 7, e42749 (2012
11. Huikuri, H. V., Castellanos, A. & Myerburg, R. J. Sudden death due to cardiac arrhythmias. N. Engl. J. Med. 345, 1473-1482 (2001
12. Zheng, Z. J., Croft, J. B., Giles, W. H. & Mensah, G. A. Sudden cardiac death in the United States, 1989 to 1998. Circulation 104, 2158-2163 (2001
13. Meyer, L et al. Incidence, causes, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age: A 30-year review. Circulation 126, 1363-1372 (2012
14. Corrado, D., Basso, C. & Thiene, G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc. Res. 50, 399-408 (2001
15. Tan, H L., Hofman, N., van Langen, I. M., van der Wal, A. C. & Wilde, A. A. Sudden unexplained death: Heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 112, 207-213 (2005
16. George, A. L. Jr. Molecular and genetic basis of sudden cardiac death. J. Clin. Invest. 123, 75-83 (2013
17. CARDIoGRAMplusC4D Consortium et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45, 25-33 (2013
18. Friedlander, Y et al. Sudden death and myocardial infarction in first degree relatives as predictors of primary cardiac arrest. Atherosclerosis 162, 211-216 (2002
19. Jouven, X., Desnos, M., Guerot, C & Ducimetière, P. Predicting sudden death in the population: The Paris Prospective Study I. Circulation 99, 1978-1983 (1999
20. Friedlander, Y. et al. Family history as a risk factor for primary cardiac arrest. Circulation 97, 155-160 (1998
21. Dekker, L. R. et al. Familial sudden death is an important risk factor for primary ventricular fibrillation: A case-control study in acute myocardial infarction patients. Circulation 114, 1140-1145 (2006
22. Kaikkonen, K. S., Kortelainen, M. L., Linna, E. & Huikuri, H. V. Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation 114, 1462-1467 (2006
23. Myers, R. H., Kiely, D. K., Cupples, L. A. & Kannel, W. B. Parental history is an independent risk factor for coronary artery disease: The Framingham Study. Am. Heart J. 120, 963-969 (1990
24. Stamler, R., Stamler, J., Riedlinger, W. F., Algera, G. & Roberts, R. H. Family (parental) history and prevalence of hypertension. Results of a nationwide screening program. JAMA 241, 43-46 (1979
25. Meigs, J. B., Cupples, L. A. & Wilson, P. W. Parental transmission of type 2 diabetes: The Framingham Offspring Study. Diabetes 49, 2201-2207 (2000
26. Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747-753 (2009
27. Bezzina, C. R. et al. Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction. Nat. Genet. 42, 688-691 (2010
28. Arking, D. E. et al. Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet. 7, e1002158 (2011
29. Rizzo, S., Pilichou, K., Thiene, G. & Basso, C. The changing spectrum of arrhythmogenic (right ventricular) cardiomyopathy. Cell Tissue Res. 348, 319-323 (2012
30. Watkins, H., Ashrafian, H. & Redwood, C. Inherited cardiomyopathies. N. Engl. J. Med. 364, 1643-1656 (2011
31. Basso, C., Corrado, D., Marcus, F. I., Nava, A. & Thiene, G. Arrhythmogenic right ventricular cardiomyopathy. Lancet 373, 1289-1300 (2009
32. Varnava, A. M. et al. Hypertrophic cardiomyopathy: Histopathological features of sudden death in cardiac troponin T disease. Circulation 104, 1380-1384 (2001
33. Schober, T. et al. Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia. Circ. Res. 111, 170-179 (2012
34. Rizzo, S. et al. Intercalated disc abnormalities, reduced Na+ current density, and conduction slowing in desmoglein 2 mutant mice prior to cardiomyopathic changes. Cardiovasc. Res. 95, 409-418 (2012
35. Cerrone, M. et al. Sodium current deficit and arrhythmogenesis in a murine model of plakophilin 2 haploinsufficiency. Cardiovasc. Res. 95, 460-468 (2012
36. Wang, Q. et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80, 805-811 (1995
37. Curran, M. E. et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80, 795-803 (1995
38. Schwartz, P. J. et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: Implications for gene-specific therapy. Circulation 92, 3381-3386 (1995
39. Wang, D. W., Yazawa, K., Makita, N., George, A. L. & Bennett, P. B. Pharmacological targeting of long QT mutant sodium channels. J. Clin. Invest. 99, 1714-1720 (1997
40. Vincent, G. M. et al. High efficacy of beta-blockers in long-QT syndrome type 1: Contribution of noncompliance and QT prolonging drugs to the occurrence of beta-blocker treatment failures. Circulation 119, 215-221 (2009
41. Barsheshet, A. et al. Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: Implications for mutation-specific response to β blocker therapy in type 1 long-QT syndrome. Circulation 125, 1988-1996 (2012
42. Heijman, J. et al. Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1. Circ. Res. 110, 211-219 (2012
43. Choveau, F. S. et al. KCNQ1 channels voltage dependence through a voltage-dependent binding of the S4-S5 linker to the pore domain. J. Biol. Chem. 286, 707-716 (2011
44. Watanabe, H. et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat. Med. 15, 380-383 (2009
45. van der Werf, C. et al. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J. Am. Coll. Cardiol. 57, 2244-2254 (2011
46. Ackerman, M. J. et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 13, 1077-1109 (2011
47. Wilde, A. A. & Behr, E. R. Genetic testing for inherited cardiac disease. Nat. Rev. Cardiol. 10, 571-583 (2013
48. Genomes Project Consortium et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56-65 (2012
49. Genomes Project Consortium. 1000 Genomes [online], http://www. 1000genomes.org/ (2012
50. Tennessen, J. A. et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337, 64-69 (2012
51. NHLBI GO Exome Sequencing Project (ESP). Exome Variant Server [online], http://evs.gs.washington.edu/EVS/ (2013
52. Jabbari, J. et al. New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia. Circ. Cardiovasc. Genet. 6, 481-489 (2013
53. Risgaard, B. et al. High prevalence of genetic variants previously associated with Brugada syndrome in new exome data. Clin. Genet. 84, 489-495 (2013
54. Rehm, H. L. Disease-targeted sequencing: A cornerstone in the clinic. Nat. Rev. Genet. 14, 295-300 (2013
55. Cooper, G. M. & Shendure, J. Needles in stacks of needles: Finding disease-causal variants in a wealth of genomic data. Nat. Rev. Genet. 12, 628-640 (2011
56. Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073-1081 (2009
57. Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248-249 (2010
58. Ware, J. S., Walsh, R., Cunningham, F., Birney, E. & Cook, S. A. Paralogous annotation of disease-causing variants in long QT syndrome genes. Hum. Mutat. 33, 1188-1191 (2012
59. Cooper, G. M. et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 15, 901-913 (2005
60. Katsanis, S. H. & Katsanis, N. Molecular genetic testing and the future of clinical genomics. Nat. Rev. Genet. 14, 415-426 (2013
61. Boycott, K. M., Vanstone, M. R., Bulman, D. E. & Mackenzie, A. E. Rare-disease genetics in the era of next-generation sequencing: Discovery to translation. Nat. Rev. Genet. 14, 681-691 (2013
62. Crotti, L. et al. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation 127, 1009-1017 (2013
63. Lynch, M. Rate, molecular spectrum, and consequences of human mutation. Proc. Natl. Acad. Sci. USA 107, 961-968 (2010
64. Marsman, R. F. et al. A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence. J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc.2013.07.091
65. Boczek, N. J. et al. Exome sequencing and systems biology converge to identify novel mutations in the L type calcium channel, CACNA1C, linked to autosomal dominant long QT syndrome. Circ. Cardiovasc. Genet. 6, 279-289 (2013
66. Schwartz, P. J. in Sudden death (eds Kulbertus, H. E. & Wellens, H. J. J.) 358-378 (Martinus Nijhoff Publishers, 1980
67. Bezzina, C. et al. A single Na+ channel mutation causing both long-QT and Brugada syndromes. Circ. Res. 85, 1206-1213 (1999
68. Crotti, L. et al. NOS1AP is a genetic modifier of the long-QT syndrome. Circulation 120, 1657-1663 (2009
69. Priori, S. G., Napolitano, C. & Schwartz, P. J. Low penetrance in the long-QT syndrome: Clinical impact. Circulation 99, 529-533 (1999
70. Priori, S. G. et al. Clinical and genetic heterogeneity of right bundle branch block and ST segment elevation syndrome: A prospective evaluation of 52 families. Circulation 102, 2509-2515 (2000
71. Brink, P. A. et al. Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation 112, 2602-2610 (2005
72. Priori, S. G. et al. Risk stratification in the long-QT syndrome. N. Engl. J. Med. 348, 1866-1874 (2003
73. Postema, P. G. et al. Founder mutations in the Netherlands: Familial idiopathic ventricular fibrillation and DPP6. Neth. Heart J. 19, 290-296 (2011
74. Schwartz, P. J. et al. Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome. J. Am. Coll. Cardiol. 51, 920-929 (2008
75. Roden, D. M. Drug-induced prolongation of the QT interval. N. Engl. J. Med. 350, 1013-1022 (2004
76. Schwartz, P. J., Priori, S. G. & Napolitano, C. How really rare are rare diseases? The intriguing case of independent compound mutations in the long QT syndrome. J. Cardiovasc. Electrophysiol. 14, 1120-1121 (2003
77. Westenskow, P., Splawski, I., Timothy, K. W., Keating, M. T. & Sanguinetti, M. C. Compound mutations: A common cause of severe long-QT syndrome. Circulation 109, 1834-1841 (2004
78. Giudicessi, J. R. & Ackerman, M. J. Prevalence and potential genetic determinants of sensorineural deafness in KCNQ1 homozygosity and compound heterozygosity. Circ. Cardiovasc. Genet. 6, 193-200 (2013
79. Kapplinger, J. D. et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm 6, 1297-1303 (2009
80. Moss, A. J. et al. Clinical aspects of type 1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 115, 2481-2489 (2007
81. Shimizu, W. et al. Genotype-phenotype aspects of type 2 long QT syndrome. J. Am. Coll. Cardiol. 54, 2052-2062 (2009
82. Tomás, M. et al. Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. J. Am. Coll. Cardiol. 55, 2745-2752 (2010
83. Bezzina, C. R. et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat. Genet. 9, 1044-1049 (2013
84. Duchatelet, S. et al. Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. Circ. Cardiovasc. Genet. 6, 354-361 (2013
85. Arking, D. E. et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat. Genet. 38, 644-651 (2006
86. Pfeufer, A. et al. Common variants at ten loci modulate the QT interval duration in the QTSCD study. Nat. Genet. 41, 407-414 (2009
87. Newton-Cheh, C. et al. Common variants at ten loci influence QT interval duration in the QTGEN study. Nat. Genet. 41, 399-406 (2009
88. Amin, A. S. et al. Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner. Eur. Heart J. 33, 714-723 (2012
89. Serre, D. et al. Differential allelic expression in the human genome: A robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genet. 4, e1000006 (2008
90. Mizusawa, Y. & Wilde, A. A. Brugada syndrome. Circ. Arrhythm. Electrophysiol. 5, 606-616 (2012
91. Crotti, L. et al. Spectrum and prevalence of mutations involving BrS1-through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: Implications for genetic testing. J. Am. Coll. Cardiol. 60, 1410-1418 (2012
92. Chambers, J. C. et al. Genetic variation in SCN10A influences cardiac conduction. Nat. Genet. 42, 149-152 (2010
93. Holm, H. et al. Several common variants modulate heart rate, PR interval and QRS duration. Nat. Genet. 42, 117-122 (2010
94. Pfeufer, A. et al. Genome-wide association study of PR interval. Nat. Genet. 42, 153-159 (2010
95. Sotoodehnia, N. et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat. Genet. 42, 1068-1076 (2010
96. Fischer, A. & Gessler, M. Hey genes in cardiovascular development. Trends Cardiovasc. Med. 13, 221-226 (2003
97. Albert, C. M. et al. Common variants in cardiac ion channel genes are associated with sudden cardiac death. Circ. Arrhythm. Electrophysiol. 3, 222-229 (2010
98. Westaway, S. K. et al. Common variants in CASQ2, GPD1L, and NOS1AP are significantly associated with risk of sudden death in patients with coronary artery disease. Circ. Cardiovasc. Genet. 4, 397-402 (2011
99. Stecker, E. C. et al. Allelic variants of SCN5A and risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm 3, 697-700 (2006
100. Burke, A. et al. Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation 112, 798-802 (2005
101. Splawski, I. et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 297, 1333-1336 (2002
102. Albert, C. M. et al. Cardiac sodium channel gene variants and sudden cardiac death in women. Circulation 117, 16-23 (2008
103. Crotti, L. et al. Torsades de pointes following acute myocardial infarction: Evidence for a deadly link with a common genetic variant. Heart Rhythm 9, 1104-1112 (2012
104. Sotoodehnia, N. et al. β2 Adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation 113, 1842-1848 (2006
105. Tseng, Z. H. et al. Common β adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery disease. Heart Rhythm 5, 814-821 (2008
106. Gavin, M. C. et al. A common variant in the β2 adrenergic receptor and risk of sudden cardiac death. Heart Rhythm 8, 704-710 (2011
107. Mikkelsson, J., Perola, M., Penttilä, A. & Karhunen, P. J. Platelet glycoprotein Ibα HPA 2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death. Circulation 104, 876-880 (2001
108. Mikkelsson, J., Perola, M., Laippala, P., Penttilä, A. & Karhunen, P. J. Glycoprotein IIIa Pl(A1/A2) polymorphism and sudden cardiac death. J. Am. Coll. Cardiol. 36, 1317-1323 (2000
109. Sotoodehnia, N. et al. Genetic variation in angiotensin-converting enzyme-related pathways associated with sudden cardiac arrest risk. Heart Rhythm 6, 1306-1314 (2009
110. Huertas-Vazquez, A. et al. A common missense variant in the neuregulin1 gene is associated with both schizophrenia and sudden cardiac death. Heart Rhythm 10, 994-998 (2013
111. Newton-Cheh, C. et al. A common variant at 9p21 is associated with sudden and arrhythmic cardiac death. Circulation 120, 2062-2068 (2009
112. Voight, B. F. et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet. 8, e1002793 (2012
113. Huertas-Vazquez, A. et al. Novel loci associated with increased risk of sudden cardiac death in the context of coronary artery disease. PLoS ONE 8, e59905 (2013
114. Arking, D. E. et al. Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest. PLoS ONE 5, e9879 (2010
115. Aouizerat, B. E. et al. GWAS for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery disease. BMC Cardiovasc. Disord. 11, 29 (2011
116. Noutsias, M. et al. Human coxsackie-adenovirus receptor is colocalized with integrins αvβ3 and αvβ5 on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: Implications for cardiotropic viral infections. Circulation 104, 275-280 (2001
117. Lim, B. et al. Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. J. Clin. Invest. 118, 2758-2770 (2008
118. Lisewski, U. et al. The tight junction protein CAR regulates cardiac conduction and cell-cell communication. J. Exp. Med. 205, 2369-2379 (2008
119. Bugert, P. et al. No evidence for an association between the rs2824292 variant at chromosome 21q21 and ventricular fibrillation during acute myocardial infarction in a German population. Clin. Chem. Lab. Med. 49, 1237-1239 (2011
120. Park, J. H. et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat. Genet. 42, 570-575 (2010
121. Kolder, I. C., Tanck, M. W. & Bezzina, C. R. Common genetic variation modulating cardiac ECG parameters and susceptibility to sudden cardiac death. J. Mol. Cell. Cardiol. 52, 620-629 (2012
122. Straus, S. M. et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J. Am. Coll. Cardiol. 47, 362-367 (2006
123. Schwartz, P. J. & Wolf, S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 57, 1074-1077 (1978
124. Chugh, S. S. et al. Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: The Oregon Sudden Unexpected Death Study. Circulation 119, 663-670 (2009
125. Kashani, A. & Barold, S. S. Significance of QRS complex duration in patients with heart failure. J. Am. Coll. Cardiol. 46, 2183-2192 (2005
126. Zimetbaum, P. J. et al. Electrocardiographic predictors of arrhythmic death and total mortality in the Multicenter Unsustained Tachycardia Trial. Circulation 110, 766-769 (2004
127. Singh, J. P. et al. Heritability of heart rate variability: The Framingham Heart Study. Circulation 99, 2251-2254 (1999
128. Friedlander, Y., Lapidos, T., Sinnreich, R. & Kark, J. D. Genetic and environmental sources of QT interval variability in Israeli families: The Kibbutz Settlements Family Study. Clin. Genet. 56, 200-209 (1999
129. den Hoed, M. et al. Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat. Genet. 45, 621-631 (2013
130. Cho, Y. S. et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat. Genet. 41, 527-534 (2009
131. Eijgelsheim, M. et al. Genome-wide association analysis identifies multiple loci related to resting heart rate. Hum. Mol. Genet. 19, 3885-3894 (2010
132. Nolte, I. M. et al. Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: Meta-analysis of three genome-wide association studies. PLoS ONE 4, e6138 (2009
133. Smith, J. G. et al. Genome-wide association studies of the PR interval in African Americans. PLoS Genet. 7, e1001304 (2011
134. Marroni, F. et al. A genome-wide association scan of RR and QT interval duration in 3 European genetically isolated populations: The EUROSPAN project. Circ. Cardiovasc. Genet. 2, 322-328 (2009
135. Kao, W. H. et al. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation 119, 940-951 (2009
136. Noseworthy, P. A. et al. Common genetic variants, QT interval, and sudden cardiac death in a Finnish population-based study. Circ. Cardiovasc. Genet. 4, 305-311 (2011
137. Pazoki, R. et al. SNPs identified as modulators of ECG traits in the general population do not markedly affect ECG traits during acute myocardial infarction nor ventricular fibrillation risk in this condition. PLoS ONE 8, e57216 (2013
138. Ritchie, M. D. et al. Genome-and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk. Circulation 127, 1377-1385 (2013
139. Janse, M. J. & Wit, A. L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol. Rev. 69, 1049-1169 (1989
140. Nattel, S., Maguy, A., Le Bouter, S. & Yeh, Y. H. Arrhythmogenic ion-channel remodeling in the heart: Heart failure, myocardial infarction, and atrial fibrillation. Physiol. Rev. 87, 425-456 (2007
141. Hindorff, L. A. et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. USA 106, 9362-9367 (2009
142. Freedman, M. et al. Principles for the post-GWAS functional characterisation of cancer risk loci. Nat. Genet. 43, 513-518 (2011
143. Kathiresan, S & Srivastava, D. Genetics of human cardiovascular disease. Cell 148, 1242-1257 (2012
144. ENCODE Project Consortium. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012
145. Visel, A. et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457, 854-858 (2009
146. May, D. et al. Large-scale discovery of enhancers from human heart tissue. Nat. Genet. 44, 89-93 (2012
147. He, A., Kong, S. W., Ma, Q. & Pu, W. T. Co occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc. Natl. Acad. Sci. USA 108, 5632-5637 (2011
148. van den Boogaard, M. et al. Genetic variation in T box binding element functionally affects SCN5A/SCN10A enhancer. J. Clin. Invest. 122, 2519-2530 (2012
149. Arnolds, D. E. et al. TBX5 drives Scn5a expression to regulate cardiac conduction system function. J. Clin. Invest. 122, 2509-2518 (2012
150. Akopian, A. N., Sivilotti, L. & Wood, J. N. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379, 257-262 (1996
151. Verkerk, A. O. et al. Functional Nav1.8 channels in intracardiac neurons: The link between SCN10A and cardiac electrophysiology. Circ. Res. 111, 333-343 (2012
152. Yang, T. et al. Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic. Circ. Res. 111, 322-332 (2012
153. Pallante, B. A. et al. Contactin 2 expression in the cardiac Purkinje fiber network. Circ. Arrhythm. Electrophysiol. 3, 186-194 (2010
154. Holm, H. et al. A rare variant in MYH6 is associated with high risk of sick sinus syndrome. Nat. Genet. 43, 316-320 (2011
155. Nature Publishing Group. ENCODE [online], http://www.nature.com/encode/ threads (2013
156. Genomes Project Consortium. 1000 Genomes Browser [online], http://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/ (2013
157. Berdowski, J. et al. Impact of onsite or dispatched automated external defibrillator use on survival after out-of-hospital cardiac arrest. Circulation 124, 2225-2232 (2011
158. Kleinjan, D. & van Heyningen, V. Long-range control of gene expression: Emerging mechanisms and disruption in disease. Am. J. Hum. Genet. 76, 8-32 (2005
159. Wang, Q. et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet. 12, 17-23 (1996